Bloomberg reports that dental implant maker Osstem Implant Co. is engaged in advanced negotiations to acquire ZimVie . By the afternoon today, shares of ZIMV were up more than 12% to $21.30 apiece. MassDevice‘s MedTech 100 Index was down more than 1%. The outlet says South Korea–based Osstem submitted a final bid for ZimVie, according […]
Mergers & Acquisitions
Autonomix licenses nerve ablation tech from RF Innovations
Autonomix Medical (Nasdaq:AMIX) announced today that it entered into a definitive licensing agreement with RF Innovations. The agreement enables Autonomix to license the intellectual property to RF Innovations’ Apex 6 radiofrequency (RF) generator. RF Innovations’ FDA-cleared Apex 6 lesions neural tissue for pain management in the peripheral nervous system. Autonomix expects to close the transaction […]
Stryker completes Artelon acquisition
Stryker announced today that it completed its previously announced acquisition of soft tissue fixation developer Artelon. Kalamazoo, Michigan-based Stryker last month announced an agreement to buy all outstanding shares of Artelon. Financial terms remain undisclosed. Artelon specializes in soft tissue fixation products for foot and ankle and sports medicine procedures. Stryker believes that the company’s […]
Edwards to acquire mitral valve company Innovalve
Edwards Lifesciences announced today that it exercised its option to acquire Innovalve Bio Medical. BTIG analysts say that Edwards expects to pay $300 million in cash at closing. Irvine, California–based Edwards made its initial investment in Innovalve in 2017. It says the company has since demonstrated progress with promising early clinical evidence for its transcatheter […]
Affluent Medical signs $16.3M mitral valve deals with Edwards
Affluent Medical announced today that it entered into a number of agreements with Edwards Lifesciences related to structural heart products. The deals cover Affluent’s Kalios adjustable mitral annulus and mitral valve technology. Under the terms of the agreements, Affluent receives $16.3 million (€15 million) upfront as a cash payment. Edwards agreed to pay $5.44 million […]
Carlyle Group in talks to buy Baxter’s kidney care spinoff for $4B
Private equity firm Carlyle Group is reportedly in talks to acquire Baxter’s kidney care spinoff, Vantive, for more than $4 billion. The Wall Street Journal reports that Carlyle Group and Baxter entered “exclusive negotiations” in late June to acquire the Vantive spinoff for $4 billion, including debt. Vantive is slated to become a standalone company […]
Alcon acquires Belkin Vision for up to $385M
Alcon this week announced it is acquiring Belkin Vision for up to $385 million. The deal includes an upfront consideration of $81 million, a cash payment of approximately $65 million, and the potential for up to $385 million in payments contingent upon rigorous sales-based milestones. Alcon is acquiring Belkin Vision’s Direct Selective Laser Trabeculoplasty (DSLT) […]
Virtual Therapeutics completes acquisition of Akili
Virtual Therapeutics announced today that it completed the tender offer to acquire all outstanding shares of Akili (Nasdaq:AKLI). The company initially commenced its tender offer at a price of $0.4340 per share on June 3. It expired at one minute after 11:59 p.m. EDT on July 1. As of the expiration date, nearly 70 million […]
Merit Medical expands endoscopy portfolio with $105M device buy
Merit Medical Systems (Nasdaq:MMSI) announced today that it executed an asset purchase agreement with EndoGastric Solutions. The agreement features a $105 million total cash consideration for EndoGastric Solutions’ EsophyX Z+ device. EndoGastric Solutions designed its device as a minimally invasive, non-pharmacological treatment for patients with GERD. EsophyX Z+ treats GERD by restoring the body’s reflux […]
ZimVie reportedly considers sale, alternative options
Bloomberg reports that ZimVie (Nasdaq:ZIMV) is considering strategic alternatives, including a potential sale of the company. The news outlet said people with knowledge of the matter, saying the company has received new takeover approaches. According to the report, ZimVie is working with an adviser to explore alternatives after potential buyers registered their interest. Bloomberg says […]
Why Abbott acquired Bigfoot Biomedical and its smart insulin pens
When Abbott (NYSE:ABT) acquired Bigfoot Biomedical in September 2023, it took the final step to build upon a multi-year relationship. The medtech giant had a long-term, vested interest in Bigfoot, a maker of a smart insulin management system. It dates back to 2017, with Abbott even leading a financing round for Bigfoot in 2020. “We […]
